|4Apr 11, 6:05 PM ET

ELRAY RESOURCES, INC. 4

4 · 180 Life Sciences Corp. · Filed Apr 11, 2025

Insider Transaction Report

Form 4
Period: 2025-03-27
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2025-03-271,000,0000 total
    From: 2024-12-27Common Stock (1,318,000 underlying)
  • Conversion

    Common Stock

    2025-03-27+1,318,0001,318,000 total
Footnotes (3)
  • [F1]On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein.
  • [F2]Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock.
  • [F3]The Series B Convertible Preferred Stock has no expiration date.

Documents

1 file
  • 4
    ownership.xmlPrimary